Table 2.

Length of Stay Among Decedents and Survivors

	LOS in days, median (IQR)
	All, n = 41,463	Decedentsa	Survivorsb	p*
		3 (1–8)	9 (5–15)
Age				<0.001
65–74	8 (4–14)	3 (1–8)	9 (5–15)
75–79	7 (3–13)	3 (1–8)	9 (6–15)
80–84	7 (3–12)	2 (1–7)	9 (6–15)
85–89	7 (2–12)	3 (1–7)	9 (6–14)
≥90	5 (2–0)	2 (1–6)	8 (5–12)
Principal diagnosis				<0.001
Sepsis	8 (3–15)	3 (1–9)	11 (7–18)
Respiratory failure	7 (4–12)	4 (1–8)	8 (5–12)
Cerebrovascular disease	5 (1–12)	2 (1–5)	11 (5–19)
Myocardial infarction	5 (1–11)	1 (1–4)	9 (5–15)
Epilepsy and convulsions	6 (4–10)	9 (5–13)	6 (4–10)
Pneumonia	9 (5–14)	6 (2–12)	10 (6–14)
Congestive heart failure	8 (4–13)	4 (1–12)	8 (5–13)
Aspiration pneumonitis	8 (5–14)	5 (1–10)	9 (6–14)
COPD	7 (5–11)	6 (2–11)	8 (5–12)
Cardiac dysrhythmias	6 (2–11)	2 (1–4)	9 (5–13)
Charlson Comorbidity Index				<0.001
0	6 (2–11)	1 (1–5)	8 (4–14)
1–2	7 (3–12)	2 (1–7)	8 (5–14)
3–4	8 (4–14)	3 (1–8)	10 (6–16)
>4	8 (4–14)	4 (1–10)	10 (6–16)

^*p-Value based on Kruskal-Wallis testing.

^aLOS for decedents is time-to-death.

^bLOS for survivors is time-to-discharge.

IQR, interquartile range; LOS, length of stay.